The role of Thymidylate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD)expression in 5-FU based chemoradiation for head and neck cancer
Project/Area Number |
20592021
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Otorhinolaryngology
|
Research Institution | Kyushu University |
Principal Investigator |
NAKASHIMA Torahiko Kyushu University, 大学病院, 講師 (00284505)
|
Co-Investigator(Kenkyū-buntansha) |
YASUMATSU Ryuji 九州大学, 医学研究院, 研究員 (00444787)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 頭頸部癌 / 放射線化学療法 / 核酸代謝酵素 / フッ化ピリミジン / TS / DPD |
Research Abstract |
Thymidylate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD) are key enzymes for 5-FU metabolism. The relationship between the expression of TS/DPD and 5-FU sensitivity in head and neck squamous carcinoma (HNSCC) cells was analyzed in vitro. Increasing the expression of TS or DPD decreased the cytotoxicity of 5-FU against HNSCC cells. Clinico-pathological analysis was also performed utilizing specimens from oral cancer and maxillary sinus cancer. There was a correlation between high TS expression and poor prognosis of the patients. Assessment of TS/DPD activity may be useful in predicting the effect and prognosis of HNSCC patients who are receiving 5-FU based chemo(radio)therapy.
|
Report
(4 results)
Research Products
(26 results)